ClinicalTrials.Veeva

Menu

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Active, not recruiting

Conditions

Ankylosing Spondylitis (AS)
Inflammatory Bowel Diseases (IBD)

Treatments

Procedure: Pinch biopsies
Procedure: Flexible sigmoidoscopy

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT02389075
14-1507
UL1TR001082 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study plans to learn more about the relationship between systemic autoimmune disease, such as inflammatory bowel disease and ankylosing spondyloarthritis, bacteria in the colon, and the changes in colon tissue.

Full description

Changes in human gut bacteria has been shown in patients with autoimmune diseases, such as inflammatory bowel diseases (IBD). The gut flora in ankylosing spondylitis (AS), an arthritis that can occur with IBD, has not been well studied. The immune cells in the colon directly interface with bacteria and may be influenced by them. The interactions between the colon immune system, bacteria and autoimmunity hasn't been studied. The study goal is to specifically study the link between bacteria, the colonic immune system, and the autoimmune diseases of AS and IBD. This will be done by collecting clinical data by questionnaires, blood samples, colonic tissue during endoscopy, and microbiome data in subjects with IBD, AS, and controls.

Enrollment

129 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Healthy Controls

Exclusion criteria:

  • Pregnancy
  • Use of antibiotics within the past 14 days†
  • Current diagnosis of colon cancer
  • Diagnosis of celiac disease
  • Diagnosis of any other rheumatologic disease such as RA, SLE, etc.
  • Chemotherapy or radiation therapy for any malignancy within the past year
  • Daily use of aspirin or NSAIDs with inability to hold the drug 7 days before and after the procedure
  • Current use of anticoagulation (LMWH,warfarin,etc.)
  • A diagnosis of HIV
  • Clostridium difficile within the past 3 months

IBD

Inclusion Criteria:

  • Established IBD (either Crohn's disease or ulcerative colitis)
  • Suspected to have IBD by a gastroenterologist and undergoing diagnostic endoscopy and biopsy. Diagnosis will be confirmed on biopsy and patients who are negative will be considered for controls based on the pathology found.

Exclusion Criteria:

  • Pregnancy
  • Use of antibiotics within the past 14 days
  • Current diagnosis of colon cancer
  • Diagnosis of celiac disease
  • Diagnosis of any other rheumatologic disease such as RA, SLE, etc.
  • Chemotherapy or radiation therapy for any malignancy within the past year
  • Daily use of aspirin or NSAIDs with inability to hold the drug 7 days before and after the procedure
  • Current use of anticoagulation (LMWH, warfarin,etc.)
  • A diagnosis of HIV
  • Clostridium difficile within the past 3 months
  • Evidence of inflammatory spinal or axial arthritis or disease based on chart review such as inflammation seen on radiographs or a diagnosis of sacroiliitis

AS:

Inclusion Criteria:

  • Diagnosed with an axial spondyloarthritis (SpA) by a rheumatologist -
  • Meet the Assessment of SpondyloArthritis international Society (ASAS) axial spondyloarthritis (SpA) criteria

Exclusion criteria:

  • Pregnancy
  • Use of antibiotics within the past 14 days
  • Current diagnosis of colon cancer
  • Diagnosis of celiac disease
  • Diagnosis of any other rheumatologic disease such as RA, SLE, etc.
  • Chemotherapy or radiation therapy for any malignancy within the past year
  • Daily use of aspirin or NSAIDs with inability to hold the drug 7 days before and after the procedure
  • Current use of anticoagulation (LMWH,warfarin,etc.)
  • A diagnosis of HIV
  • Clostridium difficile within the past 3 months
  • A known history of idiopathic macroscopic or microscopic colitis

Trial design

129 participants in 3 patient groups

Ankylosing Spondylitis
Description:
Subjects with a diagnosis of ankylosing spondylitis undergoing routine colonoscopy or willing to undergo a flexible sigmoidoscopy for research purposes only. They will be asked to fill out questionnaires, give blood, perform a rectal swab, and have pinch biopsies taken during endoscopy.
Treatment:
Procedure: Flexible sigmoidoscopy
Procedure: Pinch biopsies
Inflammatory Bowel Disease
Description:
Subjects with a diagnosis of inflammatory bowel disease undergoing routine colonoscopy. They will be asked to fill out questionnaires, give blood, perform a rectal swab, and have pinch biopsies taken during endoscopy.
Treatment:
Procedure: Pinch biopsies
Healthy Controls
Description:
Subjects without any major autoimmune diseases or pathologies undergoing routine colonoscopy. They will be asked to fill out questionnaires, give blood, perform a rectal swab, and have pinch biopsies taken during endoscopy.
Treatment:
Procedure: Pinch biopsies

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems